Evidence map›Paper›PMID 36533147›Full record

ArticleVirus evolution2022

Importation and circulation of rubella virus lineages 1E-L2 and 2B-L2c between 2018 and 2021 in China: Virus evolution and spatial-temporal transmission characteristics.

Ying Liu, Zhenzhi Han, Chuyun Kang, Aili Cui, Yan Zhang, Li Liu, Ying Chen, Lili Deng, Hua Zhao, Jun Zhou and 24 more

Abstract read
In one paragraph

Article in Virus evolution, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Ying LiuWHO WPRO Regional Reference Measles/Rubella Laboratory, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155, Changbai Road, Changping District, Beijing 102206, China.ORCID https://orcid.org/0000-0003-4030-2778
Zhenzhi HanWHO WPRO Regional Reference Measles/Rubella Laboratory, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155, Changbai Road, Changping District, Beijing 102206, China.ORCID https://orcid.org/0000-0003-1772-7946
Chuyun KangDepartment of Maternal and Child Health, School of Public Health, Peking University, Beijing, China.
Aili CuiWHO WPRO Regional Reference Measles/Rubella Laboratory, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155, Changbai Road, Changping District, Beijing 102206, China.
Yan ZhangWHO WPRO Regional Reference Measles/Rubella Laboratory, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155, Changbai Road, Changping District, Beijing 102206, China.
Li LiuInstitute of Microbiology, Sichuan Provincial Center for Disease Control and Prevention, Chengdu City, Sichuan Province China.
Ying ChenDepartment of Immunization Program, Gansu Provincial Center for Disease Control and Prevention, Lanzhou City, Gansu Province China.
Lili DengDepartment of Expanded Programme on Immunization, Guangxi Provincial Center for Disease Control and Prevention, Nanning City, Guangxi Province, China.
Hua ZhaoDepartment of Microbiological Testing, Chongqing Provincial Center for Disease Control and Prevention, Chongqing, China.
Jun ZhouInstitute of Virology, Jiangxi Provincial Center for Disease Control and Prevention, Nanchang City, Jiangxi Province, China.
Fangcai LiDepartment of Microbiological Testing, Hunan Provincial Center for Disease Control and Prevention, Changsha City, Hunan Province, China.
Shujie ZhouDepartment of Expanded Programme on Immunization, Anhui Provincial Center for Disease Control and Prevention, Hefei City, Anhui Province, China.
Daxing FengDepartment of Expanded Programme on Immunization, Henan Provincial Center for Disease Control and Prevention, Zhengzhou City, Henan Province, China.
Xiaoling TianDepartment of Immunization Program, Neimeng Provincial Center for Disease Control and Prevention, Huhehaote City, Neimeng Province, China.
Yan FengDepartment of Immunization Program, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou City, Zhejiang Province, China.
Xiaoxian CuiDivision of Microbiology, Shanghai Provincial Center for Disease Control and Prevention, Shanghai, China.
Yue LeiDepartment of Pathogenic Microbiology, Tianjin Provincial Center for Disease Control and Prevention, Tianjin, China.
Yan WangDepartment of Immunization Program, Liaoning Provincial Center for Disease Control and Prevention, Shenyang City, Liaoning Province, China.
Fang YuanDepartment of Virology, Ningxia Provincial Center for Disease Control and Prevention, Yinchuan City, Ningxia Province, China.
Lixia FanInspection and Testing Center, Qinghai Provincial Center for Disease Control and Prevention, Xining City, Qinghai Province, China.
Xiaomin TangDepartment of Virology, Guizhou Provincial Center for Disease Control and Prevention, Guiyang City, Guizhou Province, China.
Meng ChenImmunization Prevention Institute, Beijing Provincial Center for Disease Control and Prevention, Beijing, China.
Xiaofang PengInstitute of Immunization, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou City, Guangdong Province, China.
Yu GuoInstitute of Immunization, Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang City, Hebei Province, China.
Hui GaoDepartment of Disease Inspection, Shanxi Provincial Center for Disease Control and Prevention, Taiyuan City, Shanxi Province, China.
Suting WangDepartment of Expanded Programme on Immunization, Shandong Provincial Center for Disease Control and Prevention, Jinan City, Shandong Province, China.
Liqun LiDepartment of Immunization Program, Yunnan Provincial Center for Disease Control and Prevention, Kunming City, Yunnan Province, China.
Ting ZhangVirus Detection Department, Institute of Inspection and Testing, Hubei Provincial Center for Disease Control and Prevention, Wuhan City, Hubei Province, China.
Xiuying DengDepartment of Expanded Programme on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing City, Jiangsu Province, China.
Haiyun ChenMicrobiological Laboratory, Testing and Inspection Institute, Hainan Provincial Center for Disease Control and Prevention, Haikou City, Hainan Province, China.
Shuang WangDepartment of Viral Disease Control and Prevention, Jilin Provincial Center for Disease Control and Prevention, Changchun City, Jilin Province, China.
Yu MaImmunization Planning Institute, Shaanxi Provincial Center for Disease Control and Prevention, Xi'an City, Shaanxi Province, China.
Zhen ZhuWHO WPRO Regional Reference Measles/Rubella Laboratory, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155, Changbai Road, Changping District, Beijing 102206, China.
Wenbo XuWHO WPRO Regional Reference Measles/Rubella Laboratory, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155, Changbai Road, Changping District, Beijing 102206, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To better understand the importation and circulation patterns of rubella virus lineages 1E-L2 and 2B-L2c circulating in China since 2018, 3,312 viral strains collected from 27 out of 31 provinces in China between 2018 and 2021 were sequenced and analyzed with the representative international strains of lineages 1E-L2 and 2B-L2c based on genotyping region. Time-scale phylogenetic analysis revealed that the global lineages 1E-L2 and 2B-L2c presented distinct evolutionary patterns. Lineage 1E-L2 circulated in relatively limited geographical areas (mainly Asia) and showed geographical and temporal clustering, while lineage 2B-L2c strains circulated widely throughout the world and exhibited a complicated topology with several independently evolved branches. Furthermore, both lineages showed extensive international transmission activities, and phylogeographic inference provided evidence that lineage 1E-L2 strains circulating in China possibly originated from Japan, while the source of lineage 2B-L2c isolated since 2018 is still unclear. After importation into China in 2018, the spread of lineage 1E-L2 presented a three-stage transmission pattern from southern to northern China, whereas lineage 2B-L2c spread from a single point in western China to all the other four regions. These two transmission patterns allowed both imported lineages to spread rapidly across China during the 2018-9 rubella epidemic and eventually established endemic circulations. This study provides critical scientific data for rubella control and elimination in China and worldwide.

Indexed as

importationrubella virusspatial–temporal transmissionvirus evolution

Identifiers

PMID36533147
PMCPMC9752544

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.